(Q43245600)

17 November 2017

Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking Stat3. (English)

1 reference

17 November 2017

0 references

1 reference

1

1 reference

PMC publication ID

2570147

17 November 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

The American Journal of Pathology

17 November 2017

1 reference

17 November 2017

173

1 reference

17 November 2017

5

1 reference

17 November 2017

1589-1590

1 reference

Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells

17 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2570147

Serum vitamin D concentration and prostate cancer risk: a nested case-control study

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2570147

Stat3 promotes metastatic progression of prostate cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2570147

Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2570147

Nucleocytoplasmic shuttling of persistently activated STAT3.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2570147

Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2570147

Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2570147

Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2570147

Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2570147

Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2570147

Prostate cancer survival is dependent on season of diagnosis.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2570147

1,25 dihydroxyvitamin-D3 modulates JAK–STAT pathway in IL-12/IFNγ axis leading to Th1 response in experimental allergic encephalomyelitis

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18948436

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18948436

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2353/AJPATH.2008.080579

1 reference

17 November 2017

1 reference

PMC publication ID

2570147

17 November 2017

PubMed publication ID

18948436

1 reference

PMC publication ID

2570147